Concurrent Investment Advisors, LLC Humacyte, Inc. Transaction History
Concurrent Investment Advisors, LLC
- $3.71 Trillion
- Q4 2024
A detailed history of Concurrent Investment Advisors, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 32,300 shares of HUMA stock, worth $147,934. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,300
Previous 13,800
134.06%
Holding current value
$147,934
Previous $75.1 Million
117.28%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HUMA
# of Institutions
156Shares Held
35.7MCall Options Held
284KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$32.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$23.2 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$21.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$9.34 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.81 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $472M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...